Magenta Therapeutics, Inc.·4

Aug 1, 9:13 PM ET

GARDNER JASON 4

4 · Magenta Therapeutics, Inc. · Filed Aug 1, 2022

Insider Transaction Report

Form 4
Period: 2022-08-01
GARDNER JASON
DirectorSee Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-08-01+187,500187,500 total
    Exercise: $1.57Exp: 2032-07-31Common Stock (187,500 underlying)
Footnotes (1)
  • [F1]This option shall vest and become exercisable in 16 equal quarterly installments beginning on the first quarter following the vesting commencement date. The vesting commencement date is August 1, 2022.

Documents

2 files